Dry Powder Inhaler Compositions Comprising Long Acting Muscorinic Antagonists - EP2682099

The patent EP2682099 was granted to Arven Ilac Sanayi VE Ticaret on Sep 2, 2020. The application was originally filed on Jul 4, 2013 under application number EP13175125A. The patent is currently recorded with a legal status of "Revoked".

EP2682099

ARVEN ILAC SANAYI VE TICARET
Application Number
EP13175125A
Filing Date
Jul 4, 2013
Status
Revoked
May 9, 2025
Grant Date
Sep 2, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

ALFRED E TIEFENBACHERJun 1, 2021HAMM & WITTKOPPADMISSIBLE
KRAUS & LEDERER PARTGMBBJun 1, 2021KRAUS & LEDERER PARTGMBBADMISSIBLE
HOFFMANN EITLEMay 28, 2021HOFFMANN EITLEADMISSIBLE

Patent Citations (23) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
OPPOSITIONDE3345722
OPPOSITIONUS5478578
OPPOSITIONWO02098874
OPPOSITIONWO0230389
OPPOSITIONWO03017979
OPPOSITIONWO03024396
OPPOSITIONWO03024439
OPPOSITIONWO03078429
OPPOSITIONWO2004017914
OPPOSITIONWO2008103426
OPPOSITIONWO2008133900
OPPOSITIONWO2009035542
OPPOSITIONWO2011093813
OPPOSITIONWO2011093819
OPPOSITIONWO2011152804
OPPOSITIONWO2011160920
OPPOSITIONWO9311746
SEARCHEP1894568
SEARCHEP1944018
SEARCHWO2010144628
SEARCHWO2011048379
SEARCHWO2011093819
SEARCHWO2012050945

Non-Patent Literature (NPL) Citations (3) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- "Ipratropium bromide", Wikipedia, (20210125), URL: https://en.wikipedia.org/w/index.php?title=Ipratropium_bromide&oldid=1002681982, XP055814245-
OPPOSITION- "Muscarinic antagonist", Wikipedia, (20210516), URL: https://en.wikipedia.org/w/index.php?title=Muscarinic_antagonist&oldid=1023480835, XP055814244-
OPPOSITION- M. D. JONES et al., "The Influence of Fine Excipient Particles on the Performance of Carrier-Based Dry Powder Inhalation Formulations", Pharmaceutical Research, (20060808), vol. 23, doi:10.1007/s11095-006-9012-7, pages 1665 - 1674, XP019405166

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents